Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA)

CUSIP: 92337R101

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Class A common stock, $0.001 par value per share
Shares outstanding
71,297,491
Total 13F shares
53,519,938
Share change
-420,815
Total reported value
$2,365,061,400
Put/Call ratio
116%
Price per share
$44.20
Number of holders
172
Value change
-$1,769,076
Number of buys
92
Number of sells
74

Quarterly Holders Quick Answers

What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) as of Q3 2024

As of 30 Sep 2024, Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) was held by 172 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,519,938 shares. The largest 10 holders included Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., Sofinnova Investments, Inc., FMR LLC, VANGUARD GROUP INC, COMMODORE CAPITAL LP, Eversept Partners, LP, Holocene Advisors, LP, and STATE STREET CORP. This page lists 172 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.